Tissue-Derived Scaffold Composites for Reduced Batch Variation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing 3D scaffolds fail to fully replicate the unique physicochemical properties of native tissues, leading to limitations such as batch-to-batch variation, disease transmission risks, and mismatched properties, hindering their application in tissue regeneration and modeling.
Innovation Solution
Combining solutes from targeted tissues with synthetic or natural materials to form 3D scaffolding materials that mimic the extracellular matrix, allowing customization and minimizing the amount of tissue needed, thus reducing batch-to-batch variation and cost.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If allogenic and autogenic grafts are used for tissue regeneration, then tissue repair and regeneration are promoted, but limited availability, batch-to-batch variation, disease transmission risk, and mismatched physicochemical properties hinder further application
Solution Approach 1:
The patent creates synthetic scaffolds that copy the essential physicochemical properties and structural characteristics of natural extracellular matrix without using actual biological tissue. This allows replication of the beneficial biological signals while avoiding the limitations of donor tissue availability and variability.
Solution Approach 2:
The patent systematically varies parameters such as fiber diameter, pore size, crosslinking density, and material composition to optimize scaffold properties. This enables precise control over degradation rate, mechanical strength, and cellular interaction characteristics to match specific tissue regeneration requirements.
2Ease of manufacture
If simple incorporation of matrix-related molecules is done into 3D scaffolds, then some ECM functionality is achieved, but the compositional and structural complexity of native tissue matrix cannot be fully recaptured
Solution Approach 1:
The patent combines multiple biopolymer components (collagen, gelatin, chitosan, alginate) with synthetic polymers and functional molecules into composite scaffold structures. This composite approach allows simultaneous incorporation of structural support elements and bioactive signaling molecules while maintaining manufacturing feasibility.
Solution Approach 2:
The patent embeds bioactive molecules, growth factors, and signaling peptides within the hierarchical structure of the scaffold at multiple levels - from molecular incorporation into polymer chains to microencapsulation within scaffold pores - thereby capturing complexity without requiring complete replication of native matrix.
3Stability of the object's composition
If decellularized tissue matrix is used for scaffolding, then natural ECM composition is maintained, but hard-to-infiltrate cells and large batch-to-batch variation present challenges
Solution Approach 1:
The patent employs highly porous scaffold architectures with controlled pore size distributions and interconnected pore networks that facilitate deep cell infiltration and nutrient transport. The porous structure mimics the open architecture of native tissue matrix while eliminating the dense, hard-to-penetrate structure of decellularized tissues.
Solution Approach 2:
Instead of using actual decellularized tissue with its inherent batch variability, the patent synthesizes scaffolds that copy the essential compositional and structural features of natural ECM. This synthetic approach ensures consistent, reproducible properties across batches while maintaining biological functionality.
4Reliability
If 3D scaffolds are designed to replicate natural growing environment, then desirable cell phenotype expression and tissue matrix synthesis are induced, but limitations of fabrication technology and limited knowledge of natural cell environment prevent full achievement
Solution Approach 1:
The patent divides the complex task of replicating the natural tissue environment into discrete, manageable components - structural framework, mechanical properties, degradation characteristics, and individual bioactive signaling elements. Each component can be independently optimized and combined, reducing overall fabrication complexity while achieving the desired biological outcome.
Data Source
AI summary
In accordance with the method of the present invention, 3D tissue-derived scaffolding materials are made in various formats, including but not limited to hydrogel, sponge, fibers, microspheres, and films, all of which function to better preserve natural extracellular matrix molecules and to mimic the natural tissue environment, thereby effectively guiding tissue regeneration. The method involves incorporating a homogenized tissue-derived suspension into a polymeric solution of synthetic, natural, or hybrid polymers to prepare tissue-derived scaffolds in the aforementioned formats. Such tissue-derived scaffolds and scaffolding materials have a variety of utilities, including: the creation of 3D tissue models such as skin, bone, liver, pancreas, lung, and so on; facilitation of studies on cell-matrix interactions; and the fabrication of implantable scaffolding materials for guided tissue formation in vivo. The tissue-derived scaffolds and scaffolding materials made in accordance with the present invention also provide the opportunity to correlate the functions of extracellular matrix with tissue regeneration and cancer metastasis, for example.